Stamford Pharmaceuticals
Dr Migden is a distinguished US-based dermatologist and Professor, Departments of Dermatology, Division of Internal Medicine and Head and Neck Surgery, Division of Surgery at the University of Texas MD Anderson Cancer Center, Houston, TX, USA. At MD Anderson he is program director of the ACGME Fellowship:Micrographic Surgery and Dermatologic Oncology. He also serves as faculty for the Department of Ophthalmic Plastic & Reconstructive Surgery. He has served as a principal investigator for studies on the smoothened inhibitors sonidegib, vismodegib, and taladegib and.on immune therapy trials in non-melanoma skin cancer. Dr Migden has published numerous primary and expert review articles on basal cell carcinoma.
This person is not in the org chart
This person is not in any offices
Stamford Pharmaceuticals
2 followers
We are a clinical stage immunology and inflammation focused company developing novel gene therapies and biologics and applying a systems approach to creating rational combination therapies that can significantly improve patients lives.